Pregnant patients are at increased risk for COVID-19 vs nonpregnant patients. Pregnancy should be considered a ‘high risk category’ (CDC) and should be managed as such. SMFM has updated a document regarding perinatal care that provides valuable information to professionals managing women with COVID-19 during pregnancy as well as helpful counseling tips to encourage vaccination to avoid complications due to infection.
COVID-19 Disease Severity During Pregnancy
Note: Additional information regarding vaccination in pregnancy can be found below in ‘Related ObG Topics’
Therapies that would otherwise be given should not be withheld specifically due to pregnancy or lactation
Therapies including monoclonal antibodies, remdesivir, dexamethasone, baricitinib, and tocilizumab, can and should be provided to pregnant patients with COVID-19 who meet clinical qualifications
Paxlovid
SMFM supports the use of Paxlovid (nirmatrelvir [PF-07321332] tablets and ritonavir tablets) for treatment of pregnant patients with COVID-19 who meet clinical qualifications
Any therapy that would otherwise be given should not be withheld specifically due to pregnancy or lactation
Molnupiravir
Note: More information on the CDC data regarding stillbirth and COVID-19 can be found in ‘Related ObG Topics’ below
…should be a joint effort between the patient and the clinical team, including infant care providers
COVID-19 and Pregnancy: What Maternal-Fetal Medicine Subspecialists Need to Know
SMFM: FDA Issues EUA for the Treatment of Mild-to-Moderate COVID-19 (Paxlovid)
CDC: Clinical Course: Progression, Management, and Treatment
Please log in to ObGFirst to access this page